Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark

M B Damkjaer; A Perslev; F B Clausen; Morten Hanefeld Dziegiel; F S Jørgensen

doi:10.1111/j.1423-0410.2012.01602.x

Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark

M B Damkjaer, A Perslev, F B Clausen, Morten Hanefeld Dziegiel, F S Jørgensen

10 Citations (Scopus)

Abstract

Background and Objectives A targeted routine antenatal anti-D prophylaxis programme was implemented in Denmark where anti-D immunoglobulin is given based on the result from noninvasive antenatal screening for fetal RHD. Our objective was to evaluate compliance with this new programme right after its initiation. Materials and Methods We examined the treatment outcome of 239 D-negative pregnant women who gave birth at our hospital between June and September 2010. Results The majority of these women (90%) underwent antenatal RHD screening, 86% of the women who were recommended antenatal prophylaxis received anti-D, and 99% of the women who delivered RhD-positive infants received postnatal anti-D. Conclusion These compliance results are acceptable as they were obtained only a few months after the initiation of the new prophylaxis regime. However, suggestions to further improve compliance are presented.

Original language	English
Journal	Vox Sanguinis
Volume	103
Issue number	2
Pages (from-to)	145-9
Number of pages	5
ISSN	0042-9007
DOIs	https://doi.org/10.1111/j.1423-0410.2012.01602.x
Publication status	Published - Aug 2012

Keywords

Adult
Denmark
Female
Guideline Adherence
Humans
Practice Guidelines as Topic
Pregnancy
Pregnancy Complications, Hematologic
Rh Isoimmunization

Access to Document

10.1111/j.1423-0410.2012.01602.x

Cite this

@article{9fd35be98d584e0fbb56cde246124a27,

title = "Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark",

abstract = "Background and Objectives A targeted routine antenatal anti-D prophylaxis programme was implemented in Denmark where anti-D immunoglobulin is given based on the result from noninvasive antenatal screening for fetal RHD. Our objective was to evaluate compliance with this new programme right after its initiation. Materials and Methods We examined the treatment outcome of 239 D-negative pregnant women who gave birth at our hospital between June and September 2010. Results The majority of these women (90%) underwent antenatal RHD screening, 86% of the women who were recommended antenatal prophylaxis received anti-D, and 99% of the women who delivered RhD-positive infants received postnatal anti-D. Conclusion These compliance results are acceptable as they were obtained only a few months after the initiation of the new prophylaxis regime. However, suggestions to further improve compliance are presented.",

keywords = "Adult, Denmark, Female, Guideline Adherence, Humans, Practice Guidelines as Topic, Pregnancy, Pregnancy Complications, Hematologic, Rh Isoimmunization",

author = "Damkjaer, {M B} and A Perslev and Clausen, {F B} and Dziegiel, {Morten Hanefeld} and J{\o}rgensen, {F S}",

note = "{\textcopyright} 2012 The Author(s). Vox Sanguinis {\textcopyright} 2012 International Society of Blood Transfusion.",

year = "2012",

month = aug,

doi = "10.1111/j.1423-0410.2012.01602.x",

language = "English",

volume = "103",

pages = "145--9",

journal = "Vox Sanguinis",

issn = "0042-9007",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark

AU - Damkjaer, M B

AU - Perslev, A

AU - Clausen, F B

AU - Dziegiel, Morten Hanefeld

AU - Jørgensen, F S

PY - 2012/8

Y1 - 2012/8

N2 - Background and Objectives A targeted routine antenatal anti-D prophylaxis programme was implemented in Denmark where anti-D immunoglobulin is given based on the result from noninvasive antenatal screening for fetal RHD. Our objective was to evaluate compliance with this new programme right after its initiation. Materials and Methods We examined the treatment outcome of 239 D-negative pregnant women who gave birth at our hospital between June and September 2010. Results The majority of these women (90%) underwent antenatal RHD screening, 86% of the women who were recommended antenatal prophylaxis received anti-D, and 99% of the women who delivered RhD-positive infants received postnatal anti-D. Conclusion These compliance results are acceptable as they were obtained only a few months after the initiation of the new prophylaxis regime. However, suggestions to further improve compliance are presented.

AB - Background and Objectives A targeted routine antenatal anti-D prophylaxis programme was implemented in Denmark where anti-D immunoglobulin is given based on the result from noninvasive antenatal screening for fetal RHD. Our objective was to evaluate compliance with this new programme right after its initiation. Materials and Methods We examined the treatment outcome of 239 D-negative pregnant women who gave birth at our hospital between June and September 2010. Results The majority of these women (90%) underwent antenatal RHD screening, 86% of the women who were recommended antenatal prophylaxis received anti-D, and 99% of the women who delivered RhD-positive infants received postnatal anti-D. Conclusion These compliance results are acceptable as they were obtained only a few months after the initiation of the new prophylaxis regime. However, suggestions to further improve compliance are presented.

KW - Adult

KW - Denmark

KW - Female

KW - Guideline Adherence

KW - Humans

KW - Practice Guidelines as Topic

KW - Pregnancy

KW - Pregnancy Complications, Hematologic

KW - Rh Isoimmunization

U2 - 10.1111/j.1423-0410.2012.01602.x

DO - 10.1111/j.1423-0410.2012.01602.x

M3 - Journal article

C2 - 22443522

SN - 0042-9007

VL - 103

SP - 145

EP - 149

JO - Vox Sanguinis

JF - Vox Sanguinis

IS - 2

ER -

Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark

Abstract

Keywords

Access to Document

Fingerprint

Cite this